| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/14/2010 | CA2729769A1 Salts of hiv inhibitor compounds |
| 01/14/2010 | CA2729767A1 Novel compounds, pharmaceutical compositions containing same, methods of use for same, and methods for preparing same |
| 01/14/2010 | CA2729619A1 Nutritive compositions and methods of using same |
| 01/14/2010 | CA2729346A1 Topical regional neuro-affective therapy |
| 01/14/2010 | CA2729307A1 Macrocyclic indole derivatives useful as hepatitis c virus inhibitors |
| 01/14/2010 | CA2729186A1 Fatty acid acetylated salicylates and their uses |
| 01/14/2010 | CA2728344A1 Compositions for inducing immune responses specific to globo h and ssea3 and uses thereof in cancer treatment |
| 01/14/2010 | CA2728213A1 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 01/14/2010 | CA2728193A1 Controlled release treatment of depression |
| 01/14/2010 | CA2728176A1 Drug loaded polymeric nanoparticles and methods of making and using same |
| 01/14/2010 | CA2728069A1 Means and methods for counteracting, delaying and/or preventing heart disease |
| 01/14/2010 | CA2728042A1 Piperidinyl gpcr agonists |
| 01/14/2010 | CA2727918A1 L-carnitine and alkanoyl l-carnitine phytates and process for preparing the same |
| 01/14/2010 | CA2727820A1 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| 01/14/2010 | CA2727651A1 Anti-infective compounds |
| 01/14/2010 | CA2727282A1 Novel pyrrolidine derivatives as metap-2 inhibitors |
| 01/14/2010 | CA2727146A1 Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity |
| 01/14/2010 | CA2726686A1 Triazole derivatives useful for the treatment of diseases |
| 01/14/2010 | CA2726311A1 Electrostatically charged multi-acting nasal application, product, and method |
| 01/14/2010 | CA2725039A1 Nutritional composition containing oligosaccharide mixture |
| 01/14/2010 | CA2724318A1 Compositions for the treatment of hair loss |
| 01/13/2010 | EP2143792A1 Single-stranded cyclic rna, and method for production thereof |
| 01/13/2010 | EP2143727A1 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 01/13/2010 | EP2143724A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 01/13/2010 | EP2143723A1 Salt of heterocycle-substituted pyridine derivative or crystal thereof |
| 01/13/2010 | EP2143722A1 Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
| 01/13/2010 | EP2143719A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity |
| 01/13/2010 | EP2143716A1 Pyrazine derivatives, methods of use, and methods for preparing same |
| 01/13/2010 | EP2143714A1 Tetrahydroisoquinoline compound |
| 01/13/2010 | EP2143713A1 Novel pyrrolinone derivative and medicinal composition containing the same |
| 01/13/2010 | EP2143703A1 Method for the preperation of (+)-totarol |
| 01/13/2010 | EP2143445A1 Medicated patch |
| 01/13/2010 | EP2143444A1 Compositions for inhibition of anglogenesis |
| 01/13/2010 | EP2143443A1 Combined use of dipeptidyl peptidase iv inhibitor compound and sweetener |
| 01/13/2010 | EP2143441A1 Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer |
| 01/13/2010 | EP2143438A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2010 | EP2143437A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2010 | EP2143435A1 Method for extracting secoisolariciresinol and dihydroquercetin from wood |
| 01/13/2010 | EP2143434A1 Composition for promoting ketone compound formation |
| 01/13/2010 | EP2143433A1 Preparation for the prevention of joint disease |
| 01/13/2010 | EP2143432A1 9-alpha estratriene derivatives as ER-beta selective ligands for the prevention and treatment of intestinal cancer |
| 01/13/2010 | EP2143431A1 Protective agent for neurocyte comprising amidino derivative as active ingredient |
| 01/13/2010 | EP2143430A1 Drug for preventing and/or treating fatty liver or nonalcoholic fatty liver disease |
| 01/13/2010 | EP2143429A1 Use of cilastatin to reduce the nephrotoxicity of different compounds |
| 01/13/2010 | EP2143428A1 Tamibarotene capsule preparation |
| 01/13/2010 | EP2143427A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
| 01/13/2010 | EP2143425A1 Directly pressed aliskiren tablets |
| 01/13/2010 | EP2143424A1 Oral pharmaceutical preparation for colon-specific delivery |
| 01/13/2010 | EP2143423A1 Method for producing pulverized organic compound particle |
| 01/13/2010 | EP2143422A1 Ophthalmic compositions containing gemifloxacin for the treatment of ocular infections |
| 01/13/2010 | EP2143421A1 Topical composition for the treatment of actinic keratosis |
| 01/13/2010 | EP2143420A1 Formulation comprising mutant/s of lysosomal alpha-galactosidase A for the treatment of Fabry disease |
| 01/13/2010 | EP2143341A1 Nutritional Composition Containing Oligosaccharide Mixture |
| 01/13/2010 | EP2142650A2 Novel hiv-1 reverse transcriptase codon deletion and its use in the management and treatment of hiv infections |
| 01/13/2010 | EP2142649A2 Breast cancer methods, medicaments and agents |
| 01/13/2010 | EP2142636A2 Paraben compounds |
| 01/13/2010 | EP2142561A1 Process for preparing aromatase inhibitors |
| 01/13/2010 | EP2142554A1 Non-basic melanin concentrating hormone receptor-1 antagonists |
| 01/13/2010 | EP2142552A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 01/13/2010 | EP2142551A1 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors |
| 01/13/2010 | EP2142549A1 Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient |
| 01/13/2010 | EP2142544A1 Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer |
| 01/13/2010 | EP2142543A1 Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer |
| 01/13/2010 | EP2142538A1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists |
| 01/13/2010 | EP2142536A1 Aminopyrimidine derivatives as glutaminyl cyclase inhibitors |
| 01/13/2010 | EP2142535A2 3-imidazolyl-indoles for the treatment of proliferative diseases |
| 01/13/2010 | EP2142531A1 Benzimidazole cannabinoid agonists |
| 01/13/2010 | EP2142529A2 Trpv1 antagonists and uses thereof |
| 01/13/2010 | EP2142528A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus |
| 01/13/2010 | EP2142527A1 Pyridine and pyrimidine derivatives as mglur2 antagonists |
| 01/13/2010 | EP2142524A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of influenza a viral infection |
| 01/13/2010 | EP2142521A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 01/13/2010 | EP2142520A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/13/2010 | EP2142519A1 Dpp-iv inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating a diabetes or an obesity |
| 01/13/2010 | EP2142518A1 3,4-dihydroquinazoline derivatives |
| 01/13/2010 | EP2142517A2 Quinazoline compounds |
| 01/13/2010 | EP2142516A1 Pyrimidine hydrazide compounds as pgds inhibitors |
| 01/13/2010 | EP2142515A1 Novel inhibitors |
| 01/13/2010 | EP2142514A1 Thiourea derivatives as glutaminyl cyclase inhibitors |
| 01/13/2010 | EP2142513A1 Nitrovinyl-diamine derivatives as glutaminyl cyclase inhibitors |
| 01/13/2010 | EP2142512A2 Imidazolidine carboxamide derivatives as p2x7 modulators |
| 01/13/2010 | EP2142511A2 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments |
| 01/13/2010 | EP2142509A2 Quinolones and azaquinolones that inhibit prolyl hydroxylase |
| 01/13/2010 | EP2142505A1 Sulfonamides and pharmaceutical compositions thereof |
| 01/13/2010 | EP2142502A1 Pyrrole and isoindole carboxamide derivatives as p2x7 modulators |
| 01/13/2010 | EP2142500A1 Allyl sulfide compounds, and compositions and methods using said compounds for repelling blood-feeding arthropods |
| 01/13/2010 | EP2142495A1 Substituted dibenzoic acid derivatives and use thereof |
| 01/13/2010 | EP2142287A2 Lysine-specific demethylase inhibitors |
| 01/13/2010 | EP2142200A1 Homeopathy-based formulation |
| 01/13/2010 | EP2142195A1 Composition for promoting the maintenance and function of muscle-specific progenitor cells |
| 01/13/2010 | EP2142194A1 Mineralocorticoid receptor antagonists |
| 01/13/2010 | EP2142193A2 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition |
| 01/13/2010 | EP2142192A1 Compositions and kits for treating influenza |
| 01/13/2010 | EP2142190A1 Use of hdac inhibitors for the treatment of gastrointestinal cancers |
| 01/13/2010 | EP2142188A1 Methods of suppressing ltp inhibition |
| 01/13/2010 | EP2142187A2 Ibuprofen, cyclodextrines and ternary agent complexes, and pharmaceutical uses thereof |
| 01/13/2010 | EP2142186A1 Use of oligomers of lactic acid in the treatment of gynaecological disorders |
| 01/13/2010 | EP2142184A1 Use of s1p receptor modulator |
| 01/13/2010 | EP2142183A2 Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders |
| 01/13/2010 | EP2142182A1 Composition comprising terpene compounds and methods for inhibiting nerve transmission |